Insulet EBITDA 2010-2025 | PODD

Insulet EBITDA for the quarter ending March 31, 2025 was $0.111B, a 45.97% increase year-over-year.

  • Insulet 2024 EBITDA was 0.39B, a 33.09% increase from 2023.
  • Insulet 2023 EBITDA was 0.293B, a 190.48% increase from 2022.
  • Insulet 2022 EBITDA was 0.101B, a 45.04% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Insulet EBITDA 2010-2025 | PODD

  • Insulet 2024 EBITDA was 0.39B, a 33.09% increase from 2023.
  • Insulet 2023 EBITDA was 0.293B, a 190.48% increase from 2022.
  • Insulet 2022 EBITDA was 0.101B, a 45.04% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.7B
Boston Scientific (BSX)$152.7B
Stryker (SYK)$148.7B
EssilorLuxottica (ESLOY)$131.4B
Medtronic (MDT)$115.3B
Lonza Group Ag (LZAGY)$49.7B
Haleon (HLN)$44.7B
ResMed (RMD)$37.3B
Agilent Technologies (A)$35B
GE HealthCare Technologies (GEHC)$34.4B
Terumo (TRUMY)$24.6B
Koninklijke Philips (PHG)$23.1B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.7B
Smith & Nephew SNATS (SNN)$13.3B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7B
Lantheus Holdings (LNTH)$5.6B
Perrigo (PRGO)$3.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.3B
QuidelOrtho (QDEL)$2.1B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.4B